von Moltke Lisa
SEC insider (Form 3/4/5 filer). CIK 0001808592. Officer at Zenas BioPharma, Inc. (ZBIO) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in WALTHAM, MA.
Companies von Moltke Lisa has filed insider reports for
- Zenas BioPharma, Inc. (ZBIO): Officer, See Remarks
- Seres Therapeutics, Inc. (MCRB): Officer, See Remarks
von Moltke Lisa
CIK: 0001808592
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 15, 2026ZBIO
Zenas BioPharma, Inc.
AwardDirectStock Option (Right to Buy)
150K shares- - Apr 15, 2025ZBIO
Zenas BioPharma, Inc.
AwardDirectStock Option (Right to Buy)
400K shares- - Feb 18, 2025MCRB
Seres Therapeutics, Inc.
SaleDirect4.4K shares at avg. $0.81$4K - Feb 15, 2025MCRB
Seres Therapeutics, Inc.
ExerciseDirect8.9K shares- - Feb 15, 2025MCRB
Seres Therapeutics, Inc.
ExerciseDirect3K shares- - Feb 7, 2025MCRB
Seres Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
650K shares- - Nov 18, 2024MCRB
Seres Therapeutics, Inc.
SaleDirect977 shares at avg. $0.54$528.264 - Nov 15, 2024MCRB
Seres Therapeutics, Inc.
ExerciseDirect3K shares- - Oct 28, 2024MCRB
Seres Therapeutics, Inc.
SaleDirect4.3K shares at avg. $0.69$3K - Oct 27, 2024MCRB
Seres Therapeutics, Inc.
ExerciseDirect13.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  ZBIO Zenas BioPharma, Inc. | Award Stock Option (Right to Buy) | 150,000 | - | - | Direct |
| Apr 15, 2025 | ZBIO Zenas BioPharma, Inc. | Award Stock Option (Right to Buy) | 400,000 | - | - | Direct |
| Feb 18, 2025 |  MCRB Seres Therapeutics, Inc. | Sale | 4,416 | $0.81 | $3,579 | Direct |
| Feb 15, 2025 | MCRB Seres Therapeutics, Inc. | Exercise | 8,907 | - | - | Direct |
| Feb 15, 2025 | MCRB Seres Therapeutics, Inc. | Exercise | 2,969 | - | - | Direct |
| Feb 7, 2025 | MCRB Seres Therapeutics, Inc. | Award Stock Option (Right to Buy) | 650,000 | - | - | Direct |
| Nov 18, 2024 | MCRB Seres Therapeutics, Inc. | Sale | 977 | $0.54 | $528 | Direct |
| Nov 15, 2024 | MCRB Seres Therapeutics, Inc. | Exercise | 2,969 | - | $0 | Direct |
| Oct 28, 2024 | MCRB Seres Therapeutics, Inc. | Sale | 4,334 | $0.69 | $2,991 | Direct |
| Oct 27, 2024 | MCRB Seres Therapeutics, Inc. | Exercise | 13,744 | - | $0 | Direct |
1-10 of 10 transactions